YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Vioxx
Analysis: Celebrex ups heart-attack risk
Feb 28, 2006 | UPI
A meta-analysis released Tuesday indicates Pfizer's Celebrex increases the risk of a heart attack by over two-fold and experts are calling for...
Trial Date for Celebrex Suit Set for June
Feb 27, 2006 | AP
A judge set a June 6 trial date for a lawsuit filed by a woman who claims the arthritis medication Celebrex was to blame for a stroke she suffered...
Journal Continues Criticism of Vioxx Study
Feb 22, 2006 | AP
The editors of the New England Journal of Medicine published additional criticism of a Vioxx study on Wednesday even as it allowed the authors of the...
Merck Witness Testifies in Vioxx Retrial
Feb 14, 2006 | AP
Merck & Co. opened its defense in the retrial of the first federal Vioxx lawsuit with testimony about the history and workings of the...
FDA: Merck Had Time to Warn About Vioxx
Feb 10, 2006 | AP
Merck & Co. could have warned that its popular painkiller Vioxx might increase the risk of heart attacks as soon as the first evidence showed up,...
Merck Found to Have Breached UK Drug Code of Conduct by Improperly Modifying Recommended Guidelines
Feb 5, 2006 | Newsinferno News Staff
Merck & Co. is in the midst of the greatest debacle in the history of the pharmaceutical industry over claims that its embattled COX-2 inhibitor,...
Strange Goings On at the Cleveland Clinic: Mere Coincidences or Something Far More Problematic?
Dec 19, 2005 | www.newsinferno.com
If you like playing the game “connect the dots,” you might find this one very interesting:2001 – Drs. Eric Topol and his associate...
Vioxx Mistrial a Lose, Lose Situation for Merck
Dec 14, 2005 | www.newsinferno.com
The consequences of the mistrial in the first federal Vioxx trial may turn out to be extremely serious for Merck in terms of the embattled...
Merck's Bitter Pill
Dec 13, 2005 | www.motleyfool.com
"Almost" may be good enough for horseshoes and hand grenades, but in federal court, it's all or nothing. That's why Merck(NYSE: MRK) will...
Vioxx mistrial means trouble for Merck, experts say
Dec 13, 2005 | Houston Chronicle
A mistrial in the nation's first federal Vioxx trial which ended when a lone juror held out for the plaintiffs spells trouble for drug giant Merck,...
Page 10/35 [first] [prev] 1 2 3 4 5 6 7 8 9 10 ... [next] [last]
Vioxx
